Leading Companies Shape the Future of the U.S. OTC Glucose Biosensors Market
The U.S. over-the-counter glucose biosensors market, valued at USD 105.3 million in 2024, is projected to reach USD 771.6 million by 2030, exhibiting a compound annual growth rate (CAGR) of 11.5% from 2025 to 2030. This expansion is largely fueled by the rising incidence of diabetes and prediabetes, a growing emphasis on preventive healthcare, and the increasing adoption of glucose biosensors among athletes. Furthermore, the nation's aging population contributes significantly to this growth, as older individuals are more susceptible to chronic conditions like diabetes, thereby boosting the demand for effective management tools such as glucose biosensors.
